1Q17 Earnings Release
Belo Horizonte, May 10, 2017 – Alliar – Centro de Imagem Diagnósticos S.A. hereby announces its 1Q17 results.
- Net Revenue growth of 32% with 13% coming from same stores sales (SSS);
- Acquisition of Multiscan (leader in diagnostic imaging in the Espirito Santo state);
- Addition of 4 mega stores and 11 collection points; closure of 4 standard units;
- Magnetic Resonance (MRI): 6 new MRI‘s machines; 28% growth in number of exams, 22% increase in daily average occupation (22.6 exams per machine);
- Clinical Analysis (CA): 80 new clinical analysis rooms; 26% growth in number of exams, 11% average ticket increase;
- Adjusted EBITDA of R$ 49.7 million (R$ 51.3 million considering Multiscan since Jan 1st), with 20.1% margin
- Recurring operating cash flow of R$ 24.1 million, 29% growth;
- 17.2% ROIC without goodwill, increase of 141 bps;
- Net Promoter Score (NPS) of 70.5%;
Click here to access the Earnings Release.
| Conference Call in English | Conference Call in Portuguese |
|---|---|
| May 11, 2017 12:30 p.m. (Local time) 11:30 a.m. (NY time) Phone: +1 (516) 300-1066 Code: Alliar Webcast: click here |
May 11, 2017 1:30 p.m. (Local time) 12:30 p.m. (NY time) Phone: +55 (11) 3127-4971 Code: Alliar Webcast: click here |
IR Contact
Carlos Thiago de Souza Araujo
Investor Relations Officer
Email: ri@alliar.com